Indo Rama Synthetics [INDORAMA] vs Raymond [RAYMOND] Detailed Stock Comparison
Indo Rama Synthetics
NSE
Loading...
Raymond
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Indo Rama Synthetics wins in 8 metrics, Raymond wins in 10 metrics, with 0 ties. Raymond appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Indo Rama Synthetics | Raymond | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 1,028.80 | 94.29 | Raymond |
| Price-to-Book Ratio | 3.65 | 1.10 | Raymond |
| Debt-to-Equity Ratio | 308.61 | 17.81 | Raymond |
| PEG Ratio | N/A | -3.40 | N/A |
| EV/EBITDA | 9.98 | 25.32 | Indo Rama Synthetics |
| Profit Margin (TTM) | 1.59% | 271.84% | Raymond |
| Operating Margin (TTM) | 6.55% | 3.39% | Indo Rama Synthetics |
| EBITDA Margin (TTM) | 6.55% | 3.39% | Indo Rama Synthetics |
| Return on Equity | 0.38% | 183.56% | Raymond |
| Return on Assets (TTM) | 0.05% | 98.90% | Raymond |
| Free Cash Flow (TTM) | $3.52B | $752.80M | Indo Rama Synthetics |
| 1-Year Return | 17.34% | -66.92% | Indo Rama Synthetics |
| Price-to-Sales Ratio (TTM) | 0.29 | 1.98 | Indo Rama Synthetics |
| Enterprise Value | $24.37B | $44.93B | Raymond |
| EV/Revenue Ratio | 0.53 | 2.19 | Indo Rama Synthetics |
| Gross Profit Margin (TTM) | 21.95% | 40.59% | Raymond |
| Revenue per Share (TTM) | $177 | $0 | Indo Rama Synthetics |
| Earnings per Share (Diluted) | $0.05 | $6.49 | Raymond |
| Beta (Stock Volatility) | 0.22 | -0.02 | Raymond |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Indo Rama Synthetics vs Raymond Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Indo Rama Synthetics | 5.00% | 0.23% | 3.31% | 10.70% | 30.79% | 25.68% |
| Raymond | 0.06% | -3.19% | -10.89% | 11.02% | -55.76% | -63.88% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Indo Rama Synthetics | 17.34% | -18.02% | 154.02% | 67.56% | 38.84% | -30.44% |
| Raymond | -66.92% | -37.17% | 111.31% | 38.47% | 66.20% | 68.81% |
Performance & Financial Health Analysis: Indo Rama Synthetics vs Raymond
| Metric | INDORAMA | RAYMOND |
|---|---|---|
| Market Information | ||
| Market Cap | ₹13.46B | ₹40.73B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 72,808 | 375,597 |
| 90 Day Avg. Volume | 118,972 | 671,701 |
| Last Close | ₹54.01 | ₹612.30 |
| 52 Week Range | ₹32.00 - ₹59.50 | ₹523.10 - ₹2,182.00 |
| % from 52W High | -9.23% | -71.94% |
| All-Time High | ₹109.70 (Jan 12, 2004) | ₹3,496.00 (Jul 08, 2024) |
| % from All-Time High | -50.77% | -82.49% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.38% | -0.44% |
| Quarterly Earnings Growth | 0.65% | -0.28% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 2.72% |
| Operating Margin (TTM) | 0.07% | 0.03% |
| Return on Equity (TTM) | 0.00% | 1.84% |
| Debt to Equity (MRQ) | 308.61 | 17.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹14.10 | ₹558.44 |
| Cash per Share (MRQ) | ₹1.62 | ₹114.41 |
| Operating Cash Flow (TTM) | ₹886.80M | ₹69.27B |
| Levered Free Cash Flow (TTM) | ₹14.00M | ₹76.31B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Indo Rama Synthetics vs Raymond
| Metric | INDORAMA | RAYMOND |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 1,028.80 | 94.29 |
| Forward P/E | N/A | 4.72 |
| PEG Ratio | N/A | -3.40 |
| Price to Sales (TTM) | 0.29 | 1.98 |
| Price to Book (MRQ) | 3.65 | 1.10 |
| Market Capitalization | ||
| Market Capitalization | ₹13.46B | ₹40.73B |
| Enterprise Value | ₹24.37B | ₹44.93B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.53 | 2.19 |
| Enterprise to EBITDA | 9.98 | 25.32 |
| Risk & Other Metrics | ||
| Beta | 0.22 | -0.02 |
| Book Value per Share (MRQ) | ₹14.10 | ₹558.44 |
Financial Statements Comparison: Indo Rama Synthetics vs Raymond
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | INDORAMA | RAYMOND |
|---|---|---|
| Revenue/Sales | ₹11.98B | ₹5.24B |
| Cost of Goods Sold | ₹9.35B | ₹3.11B |
| Gross Profit | ₹2.63B | ₹2.13B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹650.80M | ₹177.70M |
| EBITDA | ₹1.05B | ₹852.70M |
| Pre-Tax Income | ₹510.70M | ₹282.10M |
| Income Tax | ₹0 | ₹75.90M |
| Net Income (Profit) | ₹510.70M | ₹53.28B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | INDORAMA | RAYMOND |
|---|---|---|
| Cash & Equivalents | ₹242.10M | ₹343.70M |
| Total Current Assets | ₹13.37B | ₹52.03B |
| Total Current Liabilities | ₹21.53B | ₹30.16B |
| Long-Term Debt | ₹3.66B | ₹3.45B |
| Total Shareholders Equity | ₹3.68B | ₹41.58B |
| Retained Earnings | N/A | ₹18.59B |
| Property, Plant & Equipment | ₹12.64B | ₹8.90B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | INDORAMA | RAYMOND |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | INDORAMA | RAYMOND |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 72,808 | 375,597 |
| Average Daily Volume (90 Day) | 118,972 | 671,701 |
| Shares Outstanding | 261.11M | 66.55M |
| Float Shares | 35.22M | 31.00M |
| % Held by Insiders | 0.87% | 0.52% |
| % Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Indo Rama Synthetics vs Raymond
| Metric | INDORAMA | RAYMOND |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | ₹5.33 |
| 3-Year Avg Dividend Yield | N/A | 0.31% |
| 3-Year Total Dividends | ₹0.00 | ₹16.00 |
| Ex-Dividend Date | N/A | Jun 13, 2024 |